Other publication

Switching from originator-infliximab to biosimilar-Infliximab in IBD-patients does not lead to significant changes in infliximab trough levels




AuthorsEberl A, Huoponen S, Pahikkala T, Arkkila P, Blom M, Sipponen T

PublisherOXFORD UNIV PRESS

Publication year2017

JournalJournal of Crohn's and Colitis

Journal name in sourceJOURNAL OF CROHNS & COLITIS

Journal acronymJ CROHNS COLITIS

Volume11

First page S406

Last pageS407

Number of pages2

ISSN1873-9946




Last updated on 2024-26-11 at 17:17